Evidence map›Paper›PMID 18845960›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2008

Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.

Kumud K Singh, Michael D Hughes, Jie Chen, Kelesitse Phiri, Christine Rousseau, Louise Kuhn, Anna Coutsoudis, J Brooks Jackson, Laura A Guay, Philippa Musoke and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. The application of clinical genetics · 2019
    Article
  4. CCR2 polymorphism and HIV: mutation in both mother and child is associated with higher transmission.International journal of biochemistry and molecular biology · 2019
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Kumud K SinghDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093-0672, USA.
Michael D Hughes
Jie Chen
Kelesitse Phiri
Christine Rousseau
Louise Kuhn
Anna Coutsoudis
J Brooks Jackson
Laura A Guay
Philippa Musoke
Francis Mmiro
Richard D Semba
Stephen A Spector
Johns Hopkins University · USCancer Research And Biostatistics · USMakerere University · UGUniversity of California, San Diego · USColumbia University · USHarvard University Press · USUniversity of KwaZulu-Natal · ZAUniversity of Washington · US

Funding

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
University of California, San Diego Clinical Trial UnitUM1AI069536 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEPHEN A SPECTOR · 2012 to 2026
$34.0M
University of California, San Diego Clinical Trial UnitU01AI069536 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SPECTOR, STEPHEN A · 2007 to 2011
$5.4M
PEDIATRIC AIDS--FACTORS IN TRANSMISSION AND PATHOLOGYR01AI039004 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SPECTOR, STEPHEN A · 1995 to 2005
$1.5M
NIAID NIH HHS AI-069536NIAID NIH HHS AI-36214NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI039004NIAID NIH HHS U01 AI068632NIAID NIH HHS U01 AI069536NIAID NIH HHS UM1 AI069536
6 · The paper itself

Abstract

backgroundHIV-1 mother-to-child transmission (MTCT) remains an important route of infection in sub-Saharan Africa.

methodsGenetic variants in CCR5 promoter, CCR2, CX3CR1, and Stromal cell-derived factor-1 (SDF-1) genes were determined in 980 infants from sub-Saharan Africa using real-time polymerase chain reaction to determine association with MTCT.

resultsIn antiretroviral-naive mother-infant pairs (n = 637), CCR5 promoter polymorphisms at positions 59029: A allele vs. G/G [odds ratio (OR): 1.61, 95% confidence interval (CI): 1.04 to 2.48; P = 0.032] and 59356: T allele vs. C/C (OR: 0.63, 95% CI: 0.41 to 0.96; P = 0.033) and CCR2-180: G allele vs. A/A (OR: 3.32, 95% CI: 1.13 to 9.73; P = 0.029) were associated with risk of MTCT. Treatment of HIV-1-infected mothers and infants with single-dose nevirapine or perinatal zidovudine altered but did not eliminate the association of genetic variants with MTCT.

conclusionsCCR5 promoter, CCR2, and CX3CR1 polymorphisms were associated with risk of MTCT likely through their role as an HIV-1 coreceptor or by modulating the early immune response. Host genetics may continue to alter MTCT when short-course interventions that only partially suppress virus are used. These findings will need to be confirmed in validation cohorts with a large number of infected infants.

Indexed as

HIV-1Infectious Disease Transmission, VerticalPolymorphism, GeneticAcquired Immunodeficiency SyndromeAdultAnti-HIV AgentsCX3C Chemokine Receptor 1FemaleHumansInfantMalePregnancyReceptors, CCR2Receptors, CCR5Receptors, ChemokineAnti-HIV AgentsCCR2 protein, humanCX3C Chemokine Receptor 1CX3CR1 protein, humanReceptors, CCR2Receptors, CCR5Receptors, Chemokine

Identifiers

PMID18845960
PMCPMC2748918
OpenAlexW2094945842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.